BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23830351)

  • 1. Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy.
    Yang J; Du X
    Surg Oncol; 2013 Sep; 22(3):e53-7. PubMed ID: 23830351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal imbalances in malignant peripheral nerve sheath tumor detected by metaphase and microarray comparative genomic hybridization.
    Nakagawa Y; Yoshida A; Numoto K; Kunisada T; Wai D; Ohata N; Takeda K; Kawai A; Ozaki T
    Oncol Rep; 2006 Feb; 15(2):297-303. PubMed ID: 16391845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
    Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
    Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
    Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
    Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment.
    Yang J; Ylipää A; Sun Y; Zheng H; Chen K; Nykter M; Trent J; Ratner N; Lev DC; Zhang W
    Clin Cancer Res; 2011 Dec; 17(24):7563-73. PubMed ID: 22042973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
    Miller SJ; Rangwala F; Williams J; Ackerman P; Kong S; Jegga AG; Kaiser S; Aronow BJ; Frahm S; Kluwe L; Mautner V; Upadhyaya M; Muir D; Wallace M; Hagen J; Quelle DE; Watson MA; Perry A; Gutmann DH; Ratner N
    Cancer Res; 2006 Mar; 66(5):2584-91. PubMed ID: 16510576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH.
    Kresse SH; Skårn M; Ohnstad HO; Namløs HM; Bjerkehagen B; Myklebost O; Meza-Zepeda LA
    Mol Cancer; 2008 Jun; 7():48. PubMed ID: 18522746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.
    Grobmyer SR; Reith JD; Shahlaee A; Bush CH; Hochwald SN
    J Surg Oncol; 2008 Mar; 97(4):340-9. PubMed ID: 18286466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
    Skotheim RI; Kallioniemi A; Bjerkhagen B; Mertens F; Brekke HR; Monni O; Mousses S; Mandahl N; Soeter G; Nesland JM; Smeland S; Kallioniemi OP; Lothe RA
    J Clin Oncol; 2003 Dec; 21(24):4586-91. PubMed ID: 14673046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group.
    Brekke HR; Ribeiro FR; Kolberg M; Agesen TH; Lind GE; Eknaes M; Hall KS; Bjerkehagen B; van den Berg E; Teixeira MR; Mandahl N; Smeland S; Mertens F; Skotheim RI; Lothe RA
    J Clin Oncol; 2010 Mar; 28(9):1573-82. PubMed ID: 20159821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
    Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S
    Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
    Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
    Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.
    Peacock JD; Cherba D; Kampfschulte K; Smith MK; Monks NR; Webb CP; Steensma M
    J Transl Med; 2013 Sep; 11():213. PubMed ID: 24040940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization.
    Mechtersheimer G; Otaño-Joos M; Ohl S; Benner A; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S
    Genes Chromosomes Cancer; 1999 Aug; 25(4):362-9. PubMed ID: 10398430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.
    Ahsan S; Ge Y; Tainsky MA
    Oncotarget; 2016 Aug; 7(35):57171-57185. PubMed ID: 27494873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytogenetic analysis in two cases of malignant peripheral nerve sheath tumor showing hypodiploid karyotype.
    Ishiguro M; Iwasaki H; Takeshita M; Hirose Y; Kaneko Y
    Oncol Rep; 2006 Aug; 16(2):225-32. PubMed ID: 16820897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal aberrations and microsatellite instability of malignant peripheral nerve sheath tumors: a study of 10 tumors from nine patients.
    Kobayashi C; Oda Y; Takahira T; Izumi T; Kawaguchi K; Yamamoto H; Tamiya S; Yamada T; Oda S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Cancer Genet Cytogenet; 2006 Mar; 165(2):98-105. PubMed ID: 16527603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.